The report compared infection rates for 2019 through 2022 for seven infections: Carbapenem-resistant Enterobacterales, Carbapenem-resistant Acinetobacter, Candida auris, Methicillin-resistant Staphylococcus aureus, Vancomycin-resistant Enterococcus, Extended-spectrum beta-lactamase and Multidrug-resistant Pseudomonas aeruginosa.
Of the seven infections, six have seen an increase over cases in 2019.
Comparing 2021 with 2022, five of the infections were stable and only C. auris increased. C. auris saw one of the most dramatic increases at nearly five-fold from 2019 to 2022.
Notably, Methicillin-resistant Staphylococcus aureus saw the only decrease in 2022 compared with 2021.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.